Herein, we aimed to investigate the anticancer effects of MAPK6 knockdown by using MAPK6 siRNA‐loaded PLGA nanoparticles (siMAPK6‐PLGA‐NPs) in MCF‐7 breast cancer cells. This evidence concerns the gene MAPK6 and breast carcinoma.